Electrochemical skin conductance by Sudoscan®: a new tool to predict intradialytic hypotension.
Sudoscan®
dialysis
electrochemical skin conductance
intra-dialytic hypotension
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
23 07 2021
23 07 2021
Historique:
received:
09
01
2021
pubmed:
23
5
2021
medline:
26
11
2021
entrez:
22
5
2021
Statut:
ppublish
Résumé
Intradialytic hypotension (IDH), a common complication in haemodialysis (HD) patients, is associated with multiple risk factors including cardiac dysfunction and alterations of the peripheral autonomic nervous system. To what extent dysautonomia may contribute to the occurrence of IDH remains elusive. We sought to investigate the clinical utility of Sudocan®, a device that quantifies dysautonomia, in the prediction of IDH. We conducted a prospective monocentric study in adult HD patients from July 2019 to February 2020. Dysautonomia was assessed by the measurements of hand and foot electrochemical skin conductance (ESC) using Sudocan®, before HD. The primary endpoint was the incidence of IDH (The National Kidney Foundation/Kidney-Dialysis Outcome Quality Initiative definition), according to the presence of a pathological hand and/or foot ESC value, during the 3-month study period. A total of 176 HD patients (64 ± 14 years old) were enrolled. Mean pre-dialysis HD hand and foot ESC was 45 ± 20 and 54 ± 22 µS, respectively. About 35% and 40% of patients had a pathological ESC at the hand and foot, respectively. IDH occurred in 46 patients. Logistic regression showed that pathologic pre-dialysis HD hand ESC was associated with an increased risk of IDH [odds ratio = 2.56, 95% CI (1.04-6.67), P = 0.04]. The cumulative risk incidence of IHD during the study was 5.65 [95% CI (2.04-15.71), P = 0.001] and 3.71 [95% CI (1.41-9.76), P = 0.008], with a pathological hand and foot ESC, respectively. A pathological hand ESC, as assessed by a non-invasive Sudoscan® test, is associated with an increased risk of IDH.
Sections du résumé
BACKGROUND
Intradialytic hypotension (IDH), a common complication in haemodialysis (HD) patients, is associated with multiple risk factors including cardiac dysfunction and alterations of the peripheral autonomic nervous system. To what extent dysautonomia may contribute to the occurrence of IDH remains elusive. We sought to investigate the clinical utility of Sudocan®, a device that quantifies dysautonomia, in the prediction of IDH.
METHODS
We conducted a prospective monocentric study in adult HD patients from July 2019 to February 2020. Dysautonomia was assessed by the measurements of hand and foot electrochemical skin conductance (ESC) using Sudocan®, before HD. The primary endpoint was the incidence of IDH (The National Kidney Foundation/Kidney-Dialysis Outcome Quality Initiative definition), according to the presence of a pathological hand and/or foot ESC value, during the 3-month study period.
RESULTS
A total of 176 HD patients (64 ± 14 years old) were enrolled. Mean pre-dialysis HD hand and foot ESC was 45 ± 20 and 54 ± 22 µS, respectively. About 35% and 40% of patients had a pathological ESC at the hand and foot, respectively. IDH occurred in 46 patients. Logistic regression showed that pathologic pre-dialysis HD hand ESC was associated with an increased risk of IDH [odds ratio = 2.56, 95% CI (1.04-6.67), P = 0.04]. The cumulative risk incidence of IHD during the study was 5.65 [95% CI (2.04-15.71), P = 0.001] and 3.71 [95% CI (1.41-9.76), P = 0.008], with a pathological hand and foot ESC, respectively.
CONCLUSIONS
A pathological hand ESC, as assessed by a non-invasive Sudoscan® test, is associated with an increased risk of IDH.
Identifiants
pubmed: 34021358
pii: 6280551
doi: 10.1093/ndt/gfab183
pmc: PMC8311574
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1511-1518Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA.
Références
Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1297-1303
pubmed: 29483138
Am J Kidney Dis. 2005 Apr;45(4 Suppl 3):S1-153
pubmed: 15806502
Diabetes Technol Ther. 2016 Jun;18(6):391-8
pubmed: 27057778
Semin Dial. 2017 Nov;30(6):532-536
pubmed: 28681510
Diabetes Metab. 2013 Apr;39(2):126-31
pubmed: 23159130
PLoS One. 2013;8(3):e59055
pubmed: 23536855
Semin Dial. 2013 May-Jun;26(3):333-43
pubmed: 23627490
J Am Soc Nephrol. 2011 Aug;22(8):1526-33
pubmed: 21803971
Hemodial Int. 2005 Jul;9(3):303-8
pubmed: 16191081
Diabetes Technol Ther. 2013 Nov;15(11):948-53
pubmed: 23889506
J Diabetes Complications. 2014 Jul-Aug;28(4):511-6
pubmed: 24661818
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1029-1038
pubmed: 31175104
Clin Neurophysiol. 2016 May;127(5):2222-7
pubmed: 27072093
Semin Dial. 2017 Nov;30(6):537-544
pubmed: 28730673
Am J Nephrol. 2019;49(6):497-506
pubmed: 31129661
Clin Neurophysiol. 2013 Nov;124(11):2079-90
pubmed: 23683523
PLoS One. 2015 Aug 13;10(8):e0134981
pubmed: 26270544
J Am Heart Assoc. 2020 Jan 7;9(1):e014264
pubmed: 31902281
Front Endocrinol (Lausanne). 2015 Jun 11;6:94
pubmed: 26124748
Ther Clin Risk Manag. 2016 Feb 02;12:135-8
pubmed: 26893567
Semin Dial. 2017 Nov;30(6):464-472
pubmed: 28691195
Nephrol Dial Transplant. 2008 Nov;23(11):3605-12
pubmed: 18511605
PLoS One. 2015 Oct 12;10(10):e0138224
pubmed: 26457582
J Am Soc Nephrol. 2015 Mar;26(3):724-34
pubmed: 25270068
J Am Soc Nephrol. 2017 Aug;28(8):2511-2520
pubmed: 28270412